Medgend Icon

Ledgend of Medicine







discontinued


Januvia FDA Approved Drugs

JANUVIA [Sitagliptin PhosphateC16H15F6N5OH2OH3O4P]
RX
-
eq 100mg base (oral tablet)
eq 25mg base (oral tablet)
eq 50mg base (oral tablet)
Merck Sharp DohmeOct 16, 2006
  • Improvement of glycemic control in adults with type 2 diabetes mellitus in combination with metformin and/or a ppar-gamma agonist and/or sulfonylurea and/or insulin.
  • Improvement of glycemic control in adults with type 2 diabetes mellitus in combination with metformin..
  • Improvement of glycemic control in adults with type 2 diabetes mellitus.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with insulin.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with metformin and a ppar-gamma agonist.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with a ppar-gamma agonist.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin and/or a sulfonylurea.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidaste-iv inhibitor.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.